The response of HEK293 cells transfected with bovine TLR2 to established pathogen-associated molecular patterns and to bacteria causing mastitis in cattle

Veterinary Immunology and Immunopathology

Volumn 125, Issue 3-4, 2008, Pages 326-336

  Farhat, Katja ^a   Sauter, Kay Sara ^b   Brcic, Marija ^b   Frey, Joachim ^b   Ulmer, Artur J ^a   Jungi, Thomas W ^b  

^a RESEARCH CENTER BORSTEL   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Bovine; Cattle; Escherichia coli; Interleukin 8; Lipopolysaccharide; Lipoteichoic acid; Listeria monocytogenes; Mastitis; Peptidoglycan; Staphylococcus aureus; TLR; TLR1; TLR2; TLR4; TLR6

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 8; LIPOTEICHOIC ACID; PEPTIDOGLYCAN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 6;

ARTICLE; CELL STRAIN HEK293; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ESCHERICHIA COLI; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LISTERIA MONOCYTOGENES; MACROPHAGE; MASTITIS; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTIGENS, CD36; CATTLE; CELL LINE; CLONING, MOLECULAR; FEMALE; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MASTITIS, BOVINE; NITRIC OXIDE; PEPTIDOGLYCAN; RECEPTORS, PATTERN RECOGNITION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; TEICHOIC ACIDS; TOLL-LIKE RECEPTOR 2; TRANSFECTION;

BOS; BOVINAE; ESCHERICHIA COLI; LISTERIA MONOCYTOGENES; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS UBERIS;

EID: 51549101589     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2008.05.026     Document Type: Article

References (53)

1. Adler H., Peterhans E., and Jungi T.W. Generation and functional characterization of bovine bone marrow-derived macrophages. Vet. Immunol. Immunopathol. 41 (1994) 211-227
2. Adler H., Frech B., Thony M., Pfister H., Peterhans E., and Jungi T.W. Inducible nitric oxide synthase in cattle. Differential cytokine regulation of nitric oxide synthase in bovine and murine macrophages. J. Immunol. 154 (1995) 4710-4718
3. Akashi S., Nagai Y., Ogata H., Oikawa M., Fukase K., Kusumoto S., Kawasaki K., Nishijima M., Hayashi S., Kimoto M., and Miyake K. Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition. Int. Immunol. 13 (2001) 1595-1599
4. Bannerman D.D., Paape M.J., Goff J.P., Kimura K., Lippolis J.D., and Hope J.C. Innate immune response to intramammary infection with Serratia marcescens and Streptococcus uberis. Vet. Res. 35 (2004) 681-700
5. Bannerman D.D., Paape M.J., Lee J.W., Zhao X., Hope J.C., and Rainard P. Escherichia coli and Staphylococcus aureus elicit differential innate immune responses following intramammary infection. Clin. Diagn. Lab. Immunol. 11 (2004) 463-472
6. Beutler B., Hoebe K., Du X., and Ulevitch R.J. How we detect microbes and respond to them: the Toll-like receptors and their transducers. J. Leukoc. Biol. 74 (2003) 479-485
7. Beutler B., Jiang Z., Georgel P., Crozat K., Croker B., Rutschmann S., Du X., and Hoebe K. Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu. Rev. Immunol. 24 (2006) 353-389
8. Borsutzky S., Kretschmer K., Becker P.D., Muhlradt P.F., Kirschning C.J., Weiss S., and Guzman C.A. The mucosal adjuvant macrophage-activating lipopeptide-2 directly stimulates B lymphocytes via the TLR2 without the need of accessory cells. J. Immunol. 174 (2005) 6308-6313
9. Buwitt-Beckmann U., Heine H., Wiesmüller K.H., Brock R., Jung G., Akira S., and Ulmer A.J. Toll-like receptor 6-independent signaling by diacylated lipopeptides. Eur. J. Immunol. 35 (2005) 282-289
10. Buwitt-Beckmann U., Heine H., Wiesmuller K.H., Jung G., Brock R., and Ulmer A.J. Lipopeptide structure determines TLR2 dependent cell activation level. FEBS J. 272 (2005) 6354-6364
11. Buwitt-Beckmann U., Heine H., Wiesmüller K.H., Jung G., Brock R., Akira S., and Ulmer A.J. TLR1- and TLR6-independent recognition of bacterial lipopeptides. J. Biol. Chem. 281 (2006) 9049-9057
12. Campos M.A., Almeida I.C., Tacheuchi O., Akira S., Valente E.P., Procopio D.O., Travassos L.R., Golenbock D.T., and Gazzinelli R.T. Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J. Immunol. 167 (2001) 416-423
13. Cario E., and Podolsky D.K. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect. Immun. 68 (2000) 7010-7017
14. Cauwels A., Wan E., Leismann M., and Tuomanen E. Coexistence of CD14-dependent and independent pathways for stimulation of human monocytes by Gram-positive bacteria. Infect. Immun. 65 (2007) 3255-3260
15. Edelson B.T., and Unanue E.R. MyD88-dependent but Toll-like receptor 2-independent innate immunity to Listeria: no role for either in macrophage listericidal activity. J. Immunol. 169 (2003) 3869-3875
16. Farhat K., Riekenberg S., Heine H., Debarry J., Lang R., Mages J., Buwitt-Beckmann U., Röschmann K., Jung G., Wiesmuller K.H., and Ulmer A.J. Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling. J. Leukoc. Biol. 83 (2008) 692-701
17. Flandin J.F., Charo F., and Descoteaux A. RNA interference reveals a role for TLR2 and TLR3 in the recognition of Leishmania donovani promastigotes by interferon-gamma-primed macrophages. Eur. J. Immunol. 36 (2006) 411-420
18. Flo T.H., Halaas O., Lien E., Ryan L., Teti G., Golenbock D.T., Sundan A., and Espevik T. Human toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide. J. Immunol. 164 (2000) 2064-2069
19. Franchini M., Schweizer M., Matzener P., Magkouras I., Sauter K.S., Mirkovitch J., Peterhans E., and Jungi T.W. Evidence for dissociation of TLR mRNA expression and TLR agonist-mediated functions in bovine macrophages. Vet. Immunol. Immunopathol. 110 (2006) 37-49
20. Gibson U.E., Heid C.A., and Williams P.M. A novel method for real time quantitative RT-PCR. Genome Res. 6 (1996) 995-1001
21. Goldammer T., Zerbe H., Molenaar A., Schuberth H.J., Brunner R.M., Kata S.R., and Seyfert H.M. Mastitis increases mammary mRNA abundance of beta-defensin 5, toll-like-receptor 2 (TLR2), and TLR4 but not TLR9 in cattle. Clin. Diagn. Lab. Immunol. 11 (2004) 174-185
22. Grabiec A., Meng G., Fichte S., Bessler W., Wagner H., and Kirschning C.J. Human but not murine toll-like receptor 2 discriminates between tri-palmitoylated and tri-lauroylated peptides. J. Biol. Chem. 279 (2004) 48004-48012
23. Hashimoto M., Tawaratsumida K., Kariya H., Kiyohara A., Suda Y., Krikae F., Kirikae T., and Götz F. Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus. J. Immunol. 177 (2006) 3162-3169
24. Hirschfeld M., Kirschning C.J., Schwandner R., Wesche H., Weis J.H., Wooten R.M., and Weis J.J. Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2. J. Immunol. 163 (1999) 2382-2386
25. Hoebe K., Georgel P., Rutschmann S., Du X., Mudd S., Crozat K., Sovath S., Shamel L., Hartung T., Zähringer U., and Beutler B. CD36 is a sensor of diacylglycerides. Nature 433 (2005) 523-527
26. Hoffman O., Braun J.S., Becker D., Halle A., Freyer D., Dagand E., Lehnhardt S., and Weber J.R. TLR2 mediates neuroinflammation and neuronal damage. J. Immunol. 178 (2007) 6481
27. Jin M.S., Kim S.E., Heo J.Y., Lee M.E., Kim H.M., Paik S.G., Lee H., and Lee J.O. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 130 (2007) 1071-1082
28. Jungi T.W., Thony M., Brcic M., Adler B., Pauli U., and Peterhans E. Induction of nitric oxide synthase in bovine mononuclear phagocytes is differentiation stage-dependent. Immunobiology 195 (1996) 385-400
29. Jungi T.W., Sager H., Adler H., Brcic M., and Pfister H. Serum factors, cell membrane CD14, and beta2 integrins are not required for activation of bovine macrophages by lipopolysaccharide. Infect. Immun. 65 (1997) 3577-3584
30. Kaisho T., and Akira S. Toll-like receptor function and signaling. J. Allergy Clin. Immunol. 117 (2006) 979-987
31. Kufer T.A., Banks D.J., and Philpott D.J. Innate immune sensing of microbes by Nod proteins. Ann. N. Y. Acad. Sci. 1072 (2006) 19-27
32. Li X., Bradford B.U., Dalldorf F., Goyert S.M., Stimpson S.H., Thurman R.G., and Makarov S.S. CD14 mediates the innate immune responses to arthritopathogenic peptidoglycan-polysaccharide complexes of Gram-positive bacterial cell walls. Arthritis Res. Ther. 6 (2004) R273-R281
33. Lien E., Sellati T.J., Yoshimura A., Flo T.H., Rawadi G., Finberg R.W., Carroll J.D., Espevik T., Ingalls R.R., Radolf J.D., and Golenbock D.T. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J. Biol. Chem. 274 (1999) 33419-33425
34. Lien E., Means T.K., Heine H., Yoshimura A., Kusumoto S., Fukase K., Fenton M.J., Oikawa M., Qureshi N., Monks B., Finberg R.W., Ingalls R.R., and Golenbock D.T. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J. Clin. Invest. 105 (2000) 497-504
35. Means T.K., Lien E., Yoshimura A., Wang S., Golenbock D.T., and Fenton M.J. The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors. J. Immunol. 163 (2007) 6748-6755
36. Omueti K.O., Beyer J.M., Johnson C.M., Lyle E.A., and Tapping R.I. Domain exchange between human toll-like receptors 1 and 6 reveals a region required for lipopeptide discrimination. J. Biol. Chem. 280 (2005) 36616-36625
37. Poltorak A., He X., Smirnova I., Liu M.Y., Huffel C.V., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., and Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282 (1998) 2085-2088
38. Pridmore A.C., Wyllie D.H., Abdillahi F., Seephs L., van der Ley P., Dower S.K., and Read R.C. A lipopolysaccharide-deficient mutant of Neisseria meningitidis elicits attenuated cytokine release by human macrophages and signals via toll-like receptor (TLR) 2 but not via TLR4/MD2. J. Infect. Dis. 183 (2001) 89-96
39. Rambeaud M., Almeida R.A., Pighetti G.M., and Oliver S.P. Dynamics of leukocytes and cytokines during experimentally induced Streptococcus uberis mastitis. Vet. Immunol. Immunopathol. 196 (2003) 193-205
40. Riollet C., Rainard P., and Poutrel B. Differential induction of complement fragment C5a and inflammatory cytokines during intramammary infections with Escherichia coli and Staphylococcus aureus. Clin. Diagn. Lab. Immunol. 7 (2000) 161-167
41. Roach J.C., Glusman G., Rowen L., Kaur L., Purcell M.K., Smith K.D., Hood L.E., and Aderem A. The evolution of vertebrate Toll-like receptors. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 9577-9582
42. Sauter K.S., Brcic M., Franchini M., and Jungi T.W. Stable transduction of bovine TLR4 and bovine MD-2 into LPS-nonresponsive cells and soluble CD14 promote the ability to respond to LPS. Vet. Immunol. Immunopathol. 118 (2007) 92-104
43. Schroder N.W., Opitz B., Lamping N., Michelsen K.S., Zahringer U., Gobel U.B., and Schumann R.R. Involvement of lipopolysaccharide binding protein, CD14, and Toll-like receptors in the initiation of innate immune responses by Treponema glycolipids. J. Immunol. 165 (2000) 283-293
44. Schwandner R., Dziarski R., Wesche H., Rothe M., and Kirschning C.J. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J. Biol. Chem. 274 (1999) 17406-17409
45. Takeda K., Kaisho T., and Akira S. Toll-like receptors. Annu. Rev. Immunol. 21 (2003) 335-376
46. Takeuchi O., Hoshino K., and Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol. 165 (2000) 5392-5396
47. Thoma-Uszynski S., Stenger S., Takeuchi O., Ochoa M.T., Engele M., Sieling P.A., Barnes P.F., Röllinghoff M., Bölcskey P.L., Wagner M., Akira S., Norgard M.V., Belisle J.T., Godowski P.J., Bloom B.R., and Modlin R.L. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 291 (2001) 1544-1547
48. Travassos L.H., Girardin S.E., Philpott D.J., Blanot D., Nahori M.A., Werts C., and Boneca I.G. Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Rep. 5 (2004) 1-7
49. Werling D., Hope J.C., Howard C.J., and Jungi T.W. Differential production of cytokines, reactive oxygen and nitrogen by bovine macrophages and dendritic cells stimulated with Toll-like receptor agonists. Immunology 111 (2004) 41-52
50. Werling D., Piercy J., and Coffey T.J. Expression of TOLL-like receptors (TLR) by bovine antigen-presenting cells-potential role in pathogen discrimination?. Vet. Immunol. Immunopathol. 112 (2006) 2-11
51. Werts C., Tapping R.I., Mathison J.C., Chuang T.H., Kravchenko V., Saint Girons I., Haake D.A., Godowski P.J., Hayashi F., Ozinsky A., Underhill D.M., Kirschning C.J., Wagner H., Aderem A., Tobias P.S., and Ulevitch R.J. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat. Immun. 2 (2001) 286-288
52. Yang W., Zerbe H., Petzl W., Brunner R.M., Günther J., Draing C., von Aulock S., Schuberth H.J., and Seyfert H.M. Bovine TLR2 and TLR4 properly transduce signals from Staphylococcus aureus and E. coli, but S. aureus fails to both activate NF-kappaB in mammary epithelial cells and to quickly induce TNFalpha and interleukin-8 (CXCL8) expression in the udder. Mol. Immunol. 45 (2008) 1385-1397
53. Ziegler G., Harhausen D., Schepers C., Hoffmann O., Röhr C., Prinz V., König J., Lehrach H., Nietfeld W., and Trendelenburg G. TLR2 has a detrimental role in mouse transient focal cerebral ischemia. Biochem. Biophys. Res. Commun. 359 (2007) 574-579